This post was written and published as a collaboration between the in-house editorial team at Benzinga and Tonix Pharmaceuticals Holding Corp. with...
2 days ago

Promising non-opioid treatments for fibromyalgia and acute pain emerge, as Tonix and Vertex advance innovative drugs. Learn how these developments could...
2 days ago

LAS VEGAS, NV / ACCESSWIRE / October 2, 2024 / ALT5 Sigma Corporation (NASDAQ:ALTS) ("ALT5" or the "Company"), a fintech innovator providing next-generation...
1 day ago

By Pat Anson. Fears about children becoming addicted and overdosing on opioid medication have led to the undertreatment of acute pain in pediatric patients,...
2 days ago

Global Analgesics Market reached USD 91.62 billion in 2024 and it will reach a value of USD 143.65 billion, at a CAGR of 4.6% during forecast period 2024 to...
1 day ago

ALT5 Sigma has announced a strategic plan to separate into two distinct companies. Following consummation of this plan, ALT5 will execute the separation of...
1 day ago

Vertex Pharmaceuticals (NASDAQ:VRTX) Incorporated (NASDAQ:VRTX), a leading biotechnology company, has been making significant strides in expanding its...
3 days ago

Compassion Center Austin introduces Texans to natural pain management and opioid risk reduction through the Texas Compassionate Use Program (TCUP).
6 days ago

ALT5 Sigma to split into fintech and biotech firms, boosting focus and growth. Learn how this strategic move impacts blockchain tech and pain management...
1 day ago

ALT5 Sigma (NASDAQ:ALTS) on Wednesday reported a strategic plan to separate into two distinct companies, sending shares down in premarket trade.
1 day ago